Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Accelerated, AMI, anniversary, ASCO, AU, bear, bevacizumab, biomanufacturing, BlueCrest, borrow, Canada, certainty, chlorotoxin, clause, Clive, clone, component, conflict, contact, contractor, covenant, credible, customary, DCAA, debar, decision, discretionary, dismissed, division, Eisai, employment, exceeding, FAS, flexibility, floor, FSP, Fussey, halfway, hearing, Hedging, hierarchy, Hu, induced, inibitor, instrument, intercreditor, invoked, JohnsonCarlton, Joseph, kinase, KingSteven, lender, LIBOR, lien, lieu, loan, LytlePaul, MidCap, mix, murine, noncompliant, nongovernmental, Nuclear, objectionable, occasion, organizational, Panel, passage, Peisheng, PohlDavid, possession, PRC, preclinical, prejudice, preserve, proportionately, protest, provisional, ratio, ready, reliance, relieve, relinquished, repay, repayment, segregated, Shan, Shelley, short, shortage, Simon, slight, Smith, Society, solo, spinner, stay, stayed, subcontract, subordinate, subordinated, subordination, succeeding, surpassed, SwartzEric, Taylor, thereof, thousand, tranche, TransMolecular, tyrosine, unbilled, uncured, unexpectedly, unfair, Unfavorable, Unobservable, VEGFR, viewed, Vivatuxin, Wm, worsen
Removed:
academic, accessible, analog, Anderson, animal, biodefense, characterized, circumstance, classify, Coagulation, commitment, consortium, Debenture, distributed, Enhancement, enhancing, Estate, estimating, forma, growing, humanization, humanized, Ia, Immunotherapeutic, inconsequential, incremental, involvement, Kendrick, lab, leaseback, lethal, licensee, Maker, Medarex, MGI, Michael, microenvironment, NABTT, negotiating, Northwestern, Oncolym, pancreatic, parent, Payee, payoff, PEP, permeability, Pharma, Pledge, portfolio, principally, private, pro, prodrug, prostate, pursuing, rata, Real, recovery, reserve, retained, sensitive, shipping, Southern, sublease, Subscription, summarize, supplemental, taribavirin, Tenant, TNCA, top, Triton, unusable, uptake, Valeant, Vasculature, Vertical, Viramidine, Waltz, West, wide, ZLP
Filing tables
Filing exhibits
- 10-K Annual report
- 10.12 Employment Agreement for Steven W. King, Dated March 18, 2009
- 10.13 Employment Agreement for Paul J. Lytle, Dated March 18, 2009.
- 10.14 Employment Agreement for Joseph Shan, Dated March 18, 2009.
- 10.15 Employment Agreement for Shelley P.M. Fussey, PH.D., Dated March 18, 2009.
- 21 Subsidiaries of Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32 Certification
Related press release
CDMO similar filings
Filing view
External links
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-130271, 333-121334, 333-106385, and 333-17513; Form S-3 No. 333-139975) of Peregrine Pharmaceuticals, Inc. and in the related Prospectuses of our reports dated July 10, 2009, with respect to the consolidated financial statements and schedule of Peregrine Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Peregrine Pharmaceuticals, Inc., included in the Annual Report (Form 10-K) for the year ended April 30, 2009.
/s/ Ernst & Young LLP
Orange County, California
July 10, 2009